BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

732 related articles for article (PubMed ID: 26470614)

  • 1. Hidradenitis suppurativa: Epidemiology and scope of the problem.
    Jemec GB; Kimball AB
    J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S4-7. PubMed ID: 26470614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hidradenitis suppurativa in the pediatric population.
    Liy-Wong C; Pope E; Lara-Corrales I
    J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S36-41. PubMed ID: 26470613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hidradenitis suppurativa (HS) and Down syndrome (DS): Increased prevalence and a younger age of hidradenitis symptom onset.
    Denny G; Anadkat MJ
    J Am Acad Dermatol; 2016 Sep; 75(3):632-634. PubMed ID: 27543219
    [No Abstract]   [Full Text] [Related]  

  • 4. Systemic associations of hidradenitis suppurativa.
    Kohorst JJ; Kimball AB; Davis MD
    J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S27-35. PubMed ID: 26470611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hidradenitis suppurativa: an update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life.
    Nguyen TV; Damiani G; Orenstein LAV; Hamzavi I; Jemec GB
    J Eur Acad Dermatol Venereol; 2021 Jan; 35(1):50-61. PubMed ID: 32460374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of concomitant psoriasis and hidradenitis suppurativa (HS): experience of a tertiary medical center.
    Patel M; Cohen JM; Wright NA; Merola JF; Qureshi AA; Vleugels RA
    J Am Acad Dermatol; 2015 Oct; 73(4):701-2. PubMed ID: 26369843
    [No Abstract]   [Full Text] [Related]  

  • 7. Hidradenitis suppurativa epidemiology: from the first Italian registry in 2009 to the most recent epidemiology updates - Italian Registry Hidradenitis Suppurativa project 2.
    Bettoli V; Cazzaniga S; Scuderi V; Zedde P; Di Landro A; Naldi L;
    J Eur Acad Dermatol Venereol; 2019 Oct; 33 Suppl 6():4-6. PubMed ID: 31535758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hidradenitis suppurativa: Epidemiology, clinical presentation, and pathogenesis.
    Goldburg SR; Strober BE; Payette MJ
    J Am Acad Dermatol; 2020 May; 82(5):1045-1058. PubMed ID: 31604104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of type 2 diabetes mellitus among patients with hidradenitis suppurativa in the United States.
    Garg A; Birabaharan M; Strunk A
    J Am Acad Dermatol; 2018 Jul; 79(1):71-76. PubMed ID: 29339240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hidradenitis Suppurativa: A Frequently Missed Diagnosis, Part 1: A Review of Pathogenesis, Associations, and Clinical Features.
    Wang SC; Wang SC; Sibbald RG; Alhusayen R; Bashash M; Alavi A
    Adv Skin Wound Care; 2015 Jul; 28(7):325-32; quiz 333-4. PubMed ID: 26080019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Color Doppler ultrasound assessment of morphology and types of fistulous tracts in hidradenitis suppurativa (HS).
    Wortsman X; Castro A; Figueroa A
    J Am Acad Dermatol; 2016 Oct; 75(4):760-767. PubMed ID: 27498279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiologic and clinical features of hidradenitis suppurativa.
    Parulkar I; Haleem H; Paek SY
    Semin Cutan Med Surg; 2017 Jun; 36(2):42-46. PubMed ID: 28538742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hidradenitis suppurativa is a systemic disease with substantial comorbidity burden: a chart-verified case-control analysis.
    Shlyankevich J; Chen AJ; Kim GE; Kimball AB
    J Am Acad Dermatol; 2014 Dec; 71(6):1144-50. PubMed ID: 25440440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laser and light-based treatment options for hidradenitis suppurativa.
    Hamzavi IH; Griffith JL; Riyaz F; Hessam S; Bechara FG
    J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S78-81. PubMed ID: 26470622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence of metabolic syndrome in patients with hidradenitis suppurativa.
    Gold DA; Reeder VJ; Mahan MG; Hamzavi IH
    J Am Acad Dermatol; 2014 Apr; 70(4):699-703. PubMed ID: 24433875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hidradenitis suppurativa: pathogenesis, clinical presentation, epidemiology, and comorbid associations.
    Preda-Naumescu A; Ahmed HN; Mayo TT; Yusuf N
    Int J Dermatol; 2021 Nov; 60(11):e449-e458. PubMed ID: 33890304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hidradenitis suppurativa, a review of pathogenesis, associations and management. Part 1.
    Vekic DA; Frew J; Cains GD
    Australas J Dermatol; 2018 Nov; 59(4):267-277. PubMed ID: 29355905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hidradenitis suppurativa (HS) is associated with low socioeconomic status (SES): A cross-sectional reference study.
    Deckers IE; Janse IC; van der Zee HH; Nijsten T; Boer J; Horváth B; Prens EP
    J Am Acad Dermatol; 2016 Oct; 75(4):755-759.e1. PubMed ID: 27453539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed Diagnosis of Hidradenitis Suppurativa and Its Effect on Patients and Healthcare System.
    Kokolakis G; Wolk K; Schneider-Burrus S; Kalus S; Barbus S; Gomis-Kleindienst S; Sabat R
    Dermatology; 2020; 236(5):421-430. PubMed ID: 32610312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hidradenitis Suppurativa Associated with Down Syndrome Is Characterized by Early Age at Diagnosis.
    Giovanardi G; Chiricozzi A; Bianchi L; De Simone C; Dini V; Franceschini C; Garcovich S; Oranges T; Di Raimondo C; Caposiena Caro DR; Romanelli M; Peris K
    Dermatology; 2018; 234(1-2):66-70. PubMed ID: 29689550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.